查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1535302

DNA序列的到市场规模，占有率，预测，趋势分析:各产品，各技术，各用途，各终端用户 - 2031年为止的世界预测

DNA Sequencing Market Size, Share, Forecast, & Trends Analysis by Offering (Kits & Reagents [DNA Extraction, Library Preparation, QC], Instruments, Software), Technology (NGS, Sanger), Application (Clinical, Research) End User - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 235 Pages | 订单完成后即时交付

价格

预计到 2031 年，全球 DNA 定序市场将达到 213 亿美元，2024 年至 2031 年复合年增长率为 11.8%。

经过广泛的二次和初步研究以及对市场情景的详细分析，本报告对关键行业推动因素、阻碍因素、挑战和机会进行了分析。

DNA定序市场的成长是由定序成本的下降、癌症和遗传疾病发生率的增加、DNA定序在诊断和个人化医疗中的使用增加以及药品研发投资的增加所推动的它受到多种因素的推动，包括积极的监管和报销政策、高额医疗保健支出、测序技术的进步以及政府支持的旨在促进测序技术在临床和研究应用中使用的举措。然而，定序耗材的高成本、精准医学中可操作变异的识别有限以及与基于 DNA 序列的诊断相关的伦理和法律问题等因素正在抑制这种增长。

此外，DNA 定序应用的扩大、政府对各种基因组学项目的支持、靶向治疗的认识和采用的提高以及新兴市场的经济增长预计将为在该市场运营的公司提供增长机会。然而，监管的不确定性、小型实验室的专业知识和测序能力有限、新兴市场缺乏测序专家以及 NGS 基础设施所需的高资本是限制市场成长的一些挑战。

该市场的主要趋势包括新兴 DNA 定序公司专注于技术进步和成本降低，以及领先公司专注于开发便携式和即时定序技术 You can。

本报告根据主要公司的产品组合和区域分布提供了竞争格局，并对每家公司过去几年（2021-2024 年）采用的主要成长策略进行了广泛评估。全球DNA定序市场的主要公司有Illumina, Inc.（美国）、Thermo Fisher Scientific Inc.（美国）、F. Hoffmann-La Roche Ltd.（瑞士）、Revvity, Inc.（瑞士）、Revvity、 Inc.（美国）、QIAGEN NV（荷兰）、Agilent Technologies, Inc.（美国）、Pacific Biosciences of California, Inc.（美国）、Danaher Corporation（美国）、Bio-Rad Laboratories, Inc.（美国）、牛津Nanopore Technologies Plc .（英国）和华大智造科技有限公司（中国）。

在本报告研究的产品中，耗材预计到 2024 年将主导 DNA 定序市场，占总占有率的 73.4%。这一巨大的市场占有率归因于最终用户对消耗品的需求不断增加、样品製备材料的频繁使用、可承受性的提高以及基因组作图计划的扩展。

在本报告调查的应用中，研究和其他应用领域预计到 2024 年将主导 DNA 定序市场，占总占有率的 67.2%。这一巨大的市场占有率是由测序方法成本下降、製药和生物技术公司对药物发现的研发投资增加、NGS在各种临床和研究环境中的日益使用、药理学靶标的识别、资讯学的应用推动的。

在本报告调查的最终用户中，製药和生技公司预计到 2024 年将主导 DNA 定序市场，占总占有率的 44.7%。这一巨大的市场占有率是由于製药和生物技术公司研发支出的增加，以及慢性病的流行刺激了下一代定序产品的采用。

对全球 DNA 定序市场区域状况的详细分析提供了五个主要区域（北美、欧洲、亚太地区、拉丁美洲、中东和非洲）的详细定性和定量见解，并提供了主要国家的覆盖范围。到2024年，北美预计将主导市场，占总占有率的49.0%。另据预测，到2024年，美国将主导北美DNA定序市场。该地区巨大的市场占有率归因于政府对基因组研究的支持、基于测序的研究的扩大使用、下一代测序技术主要提供者的存在、製药和生物製药公司增加的研究投资以及较低的测序成本。这归因于多种因素，包括需求下降、先进定序产品和解决方案的广泛使用、癌症发病率上升以及该地区有利的报销环境。

调查范围:

DNA序列市场评估 - 各产品

  • 消耗品
    • 样品製作套件及试剂
  • DNA萃取及放大
  • 品管
  • 其他的套件·试剂
    • 其他的消耗品
  • 设备
  • 软体
  • 服务

注意：其他试剂盒和试剂包括稀释缓衝液、DNA 标准品、DNA 净化试剂、目标富集试剂和其他试剂。

DNA序列市场评估 - 各技术

  • 下一代序列
    • 合成的序列
    • 离子半导体序列
    • DNA奈米球序列
    • 单分子即时序列
    • 其他的NGS技术
  • 桑格定序及焦磷酸测序

註:其他的NGS技术奈米孔洞序列和AVITI序列

DNA序列市场评估 - 各用途

  • 研究及其他的用途
    • 药物研发
    • 农业·动物研究
    • 其他的用途
  • 临床应用
    • 生殖医疗
    • 肿瘤学
    • 感染疾病
    • 其他临床应用

註：其他应用包括食品微生物学、食品和饮料行业的微生物组分析以及环境研究。

註：其他临床应用包括检测神经系统疾病、罕见疾病、代谢疾病和免疫疾病的遗传异常。

DNA 定序市场评估 - 按最终用户

  • 製药和生技公司
  • 医院和诊断实验室
  • 学术机构与研究中心
  • 其他最终用户

註：其他最终使用者包括法医实验室和安全机构、食品和饮料公司、农业公司等。

DNA序列市场评估 - 各地区

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 英国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 南美
    • 巴西
    • 墨西哥
    • 其他南美国家
  • 中东·非洲

目录

第1章 简介

第2章 调查手法

第3章 摘要整理

第4章 市场洞察

  • 概要
  • 市场成长的影响要素
    • 市场动态的影响分析
    • 要素分析
  • 价格分析
  • 产业趋势
    • 新兴 DNA 定序公司专注于改进技术和降低成本
    • 主要市场参与者对 PortTable 和即时定序技术的关注
  • 法规分析
    • 北美
    • 欧洲
    • 亚太地区
    • 南美
    • 中东
  • 波特的五力分析

第5章 DNA序列市场评估:各产品

  • 概要
  • 消耗品
    • 样品製作套件及试剂
    • 其他的消耗品
  • 设备
  • 软体
  • 服务

第6章 DNA序列的全球市场的评估:各技术

  • 概要
  • 下一代序列
    • 合成序列
    • 离子半导体序列
    • 单分子即时序列
    • DNA奈米球序列
    • 其他的NGS序列技术
  • 桑格定序和焦磷酸测序

第7章 DNA序列市场评估:各用途

  • 概要
  • 研究及其他的用途
    • 药物研发
    • 农业·动物研究
    • 其他的用途
  • 临床应用
    • 肿瘤学
    • 生殖医疗
    • 感染疾病
    • 其他临床应用

第8章 DNA序列市场评估:各终端用户

  • 概要
  • 製药企业及生物科技企业
  • 医院·诊断研究所
  • 学术·研究机关
  • 其他的终端用户

第9章 DNA序列市场评估:各地区

  • 概要
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 南美
    • 巴西
    • 墨西哥
    • 其他南美国家
  • 中东·非洲

第10章 竞争分析

  • 概要
  • 主要成长策略
  • 竞争基准
  • 竞争仪表板
    • 产业领导者
    • 市场差异化要素
    • 领先企业
    • 新兴企业
  • 市场占有率分析(2023年)
    • Illumina, Inc.(U.S.)
    • Thermo Fisher Scientific Inc.(U.S.)
    • MGI Tech Co., Ltd.(China)
    • Agilent Technologies, Inc.(U.S.)
    • QIAGEN N.V.(Netherlands)

第11章 企业简介(企业概要，财务概要，产品系列，策略性展开，SWOT分析)

  • Illumina, Inc.(U.S.)
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • MGI Tech Co., Ltd.
  • F. Hoffmann-La Roche Ltd
  • Revvity, Inc.
  • Pacific Biosciences of California Inc.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Oxford Nanopore Technologies Plc.
  • Other Companies

第12章 附录

Product Code: MRHC - 1041309

DNA Sequencing Market Size, Share, Forecast, & Trends Analysis by Offering (Kits & Reagents [DNA Extraction, Library Preparation, QC], Instruments, Software), Technology (NGS, Sanger), Application (Clinical, Research) End User-Global Forecast to 2031

The global DNA sequencing market is projected to reach $21.30 billion by 2031 at a CAGR of 11.8% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities.

The DNA sequencing market's growth is driven by several factors, including the decreasing costs of sequencing, the rising incidence of cancer and genetic disorders, the rising use of DNA sequencing in diagnostics and personalized medicine, increased pharmaceutical R&D investments, favorable regulatory and reimbursement policies, high healthcare expenditures, advances in sequencing technology, and supportive government initiatives aimed at promoting the use of sequencing technology in clinical & research applications. However, factors such as the high cost of sequencing consumables, limited identification of actionable mutations for precision medicine, and ethical and legal concerns related to DNA sequencing-based diagnostics restrain this growth.

Moreover, the expanding applications of DNA sequencing, government support for extensive genomic projects, growing awareness and adoption of targeted therapies, and economic growth in emerging markets are anticipated to offer growth opportunities for companies operating in this market. However, regulatory uncertainties, limited expertise & sequencing capabilities among smaller laboratories, a shortage of sequencing professionals in developing regions, and the substantial capital required for NGS infrastructure are some of the challenges impeding the market's growth.

Key trends in this market include the focus of emerging DNA sequencing companies on technological advancements and cost reduction and the emphasis by major players on developing portable and real-time sequencing technologies.

The report offers a competitive landscape based on an extensive assessment of the key players' product portfolios and geographical presence and the key growth strategies adopted by them over the past few years (2021-2024). The key players operating in the global DNA sequencing market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), and MGI Tech Co., Ltd. (China).

Among the offerings studied in this report, in 2024, the consumables segment is projected to dominate the DNA sequencing market, capturing 73.4% of the total share. The significant market share is attributed to the growing demand for consumables from end users, frequent use of sample preparation materials, increasing affordability, and the expansion of genome mapping programs.

Among the applications studied in this report, in 2024, the research & other applications segment is projected to dominate the DNA sequencing market, capturing 67.2% of the total share. The significant market share is attributed to several factors: the declining cost of sequencing procedures, increased R&D investments by pharmaceutical and biotechnology companies in drug discovery, the expanding use of NGS in various clinical and research settings, and the application of informatics solutions to identify pharmacological targets, validate therapeutic hypotheses, and assess the potential safety of inhibitory compounds targeting molecular sites.

Among the end users studied in this report, in 2024, the pharmaceutical & biotechnology companies segment is projected to dominate the DNA sequencing market, capturing 44.7% of the total share. The significant market share is attributed to increased R&D expenditures by pharmaceutical & biotechnology companies and the growing prevalence of chronic diseases, which are fueling the adoption of next-generation sequencing products.

An in-depth analysis of the geographical scenario of the global DNA sequencing market provides detailed qualitative and quantitative insights into five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is projected to dominate the market, capturing 49.0% of the total share. Additionally, in 2024, the U.S. is expected to dominate the DNA sequencing market in North America. The region's significant market share can be attributed to several factors, including supportive government initiatives for genomic research, expanding applications of sequencing-based studies, the presence of leading next-generation sequencing technology providers, rising research investments by pharmaceutical and biopharmaceutical companies, decreasing sequencing costs, wide availability of advanced sequencing products and solutions, increasing cancer prevalence, and a favorable reimbursement environment in the region.

Scope of the Report:

DNA Sequencing Market Assessment-by Offering

  • Consumables
    • Sample Preparation Kits & Reagents
  • DNA Extraction & Amplification
  • Quality Control
  • Other Kits & Reagents
    • Other Consumables
  • Instruments
  • Software
  • Services

Note: Other Kits & Reagents Include dilution buffers, DNA standards, reagents for DNA cleanup, target enrichment, and other reagents

DNA Sequencing Market Assessment -by Technology

  • Next-Generation Sequencing
    • Sequencing by Synthesis
    • Ion Semiconductor Sequencing
    • DNA Nanoball Sequencing
    • Single-molecule Real-time Sequencing
    • Other NGS Technologies
  • Sanger Sequencing & Pyrosequencing

Note: Other NGS Technologies Nanopore Sequencing and AVITI Sequencing

DNA Sequencing Market Assessment -by Application

  • Research & Other Applications
    • Drug Discovery
    • Agriculture & Animal Research
    • Other Applications
  • Clinical Applications
    • Reproductive Health
    • Oncology
    • Infectious Diseases
    • Other Clinical Applications

Note: Other Applications include food microbiology, microbiota analysis in the beverage industry, and environmental studies.

Note: Other Clinical Applications include the detection of genetic aberrations in neurological disorders, rare diseases, and metabolic and immune disorders.

DNA Sequencing Market Assessment-by End User

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Academic Institutes & Research Centers
  • Other End Users

Note: Other End Users include forensic laboratories & security agencies, food & beverage companies, and agriculture companies.

DNA Sequencing Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Process of Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of The Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Impact Analysis of Market Dynamics
    • 4.2.2. Factor Analysis
  • 4.3. Pricing Analysis
  • 4.4. Industry Trends
    • 4.4.1. Emerging DNA Sequencing Companies' Focus on Improving Technologies and Reducing Costs
      • 4.4.1.1. Singular Genomics Systems, Inc. (U.S.)
      • 4.4.1.2. Ultima Genomics, Inc. (U.S.)
      • 4.4.1.3. Element Biosciences (U.S.)
    • 4.4.2. Key Market Players' Emphasis on PorTable and Real-Time Sequencing Technologies
  • 4.5. Regulatory Analysis
    • 4.5.1. North America
      • 4.5.1.1. U.S.
      • 4.5.1.2. Canada
    • 4.5.2. Europe
    • 4.5.3. Asia-Pacific
      • 4.5.3.1. China
      • 4.5.3.2. Japan
      • 4.5.3.3. India
    • 4.5.4. Latin America
    • 4.5.5. Middle East
  • 4.6. Porter's Five Forces Analysis

5. DNA Sequencing Market Assessment-by Offering

  • 5.1. Overview
  • 5.2. Consumables
    • 5.2.1. Sample Preparation Kits & Reagents
      • 5.2.1.1. Library Preparation
      • 5.2.1.2. DNA Extraction & Amplification
      • 5.2.1.3. Quality Control
      • 5.2.1.4. Other Kits & Reagents
    • 5.2.2. Other Consumables
  • 5.3. Instruments
  • 5.4. Software
  • 5.5. Services

6. Global DNA Sequencing Market Assessment-by Technology

  • 6.1. Overview
  • 6.2. Next-generation Sequencing
    • 6.2.1. Sequencing by Synthesis
    • 6.2.2. Ion Semiconductor Sequencing
    • 6.2.3. Single-molecule Real-Time Sequencing
    • 6.2.4. DNA Nanoball Sequencing
    • 6.2.5. Other NGS Sequencing Technologies
  • 6.3. Sanger Sequencing & Pyrosequencing

7. DNA Sequencing Market Assessment-by Application

  • 7.1. Overview
  • 7.2. Research & Other Applications
    • 7.2.1. Drug Discovery
    • 7.2.2. Agricultural & Animal Research
    • 7.2.3. Other Applications
  • 7.3. Clinical Applications
    • 7.3.1. Oncology
    • 7.3.2. Reproductive Health
    • 7.3.3. Infectious Diseases
    • 7.3.4. Other Clinical Applications

8. DNA Sequencing Market Assessment-by End User

  • 8.1. Overview
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Hospitals & Diagnostic Laboratories
  • 8.4. Academic & Research Institutes
  • 8.5. Other End Users

9. DNA Sequencing Market Assessment-by Geography

  • 9.1. Overview
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe (ROE)
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific (ROAPAC)
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America (ROLATAM)
  • 9.6. Middle East & Africa (MEA)

10. Competition Analysis

  • 10.1. Overview
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Competitive Dashboard
    • 10.4.1. Industry Leaders
    • 10.4.2. Market Differentiators
    • 10.4.3. Vanguards
    • 10.4.4. Emerging Companies
  • 10.5. Market Share Analysis (2023)
    • 10.5.1. Illumina, Inc. (U.S.)
    • 10.5.2. Thermo Fisher Scientific Inc. (U.S.)
    • 10.5.3. MGI Tech Co., Ltd. (China)
    • 10.5.4. Agilent Technologies, Inc. (U.S.)
    • 10.5.5. QIAGEN N.V. (Netherlands)

11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis)

  • 11.1. Illumina, Inc. (U.S.)
  • 11.2. Thermo Fisher Scientific Inc.
  • 11.3. QIAGEN N.V.
  • 11.4. Agilent Technologies, Inc.
  • 11.5. MGI Tech Co., Ltd.
  • 11.6. F. Hoffmann-La Roche Ltd
  • 11.7. Revvity, Inc.
  • 11.8. Pacific Biosciences of California Inc.
  • 11.9. Danaher Corporation
  • 11.10. Bio-Rad Laboratories, Inc.
  • 11.11. Oxford Nanopore Technologies Plc.
  • 11.12. Other Companies

12. Appendix

  • 12.1. Available Customization
  • 12.2. Related Reports

LIST OF TABLES

  • Table 1 Number of New Cancer Cases, by Type, 2022 VS. 2040
  • Table 2 Common Genetic Disorders: Rates of Occurrence
  • Table 3 Major Genome Sequencing Projects, by Country
  • Table 4 Health Expenditure, by Country
  • Table 5 DNA Sequencing Kits & Reagents: Pricing
  • Table 6 DNA Sequencing Instruments: Product Description & Pricing
  • Table 7 G4 Specifications
  • Table 8 UG 100 Specifications
  • Table 9 AVITI Specifications
  • Table 10 Regulatory Authorities Governing In Vitro Diagnostics, by Country/REGION
  • Table 11 Global DNA Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 12 Global DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 13 Global DNA Sequencing Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 14 Global Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 15 Global Sample Preparation Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 16 Global Library Preparation Market, by Country/Region, 2022-2031 (USD Million)
  • Table 17 Global DNA Extraction & Amplification Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 18 Global Quality Control Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 19 Global Other Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 20 Global Other Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 21 Some of the Companies offering NGS Instruments for DNA Sequencing Are As Follows:
  • Table 22 Global DNA Sequencing Instruments Market, by Country/Region, 2022-2031 (USD Million)
  • Table 23 Key Players Offering DNA Sequencing Software
  • Table 24 Global DNA Sequencing Software Market, by Country/Region, 2022-2031 (USD Million)
  • Table 25 Key Players Offering Instrument-related Services
  • Table 26 Global DNA Sequencing Services Market, by Country/Region, 2024-2031 (USD Million)
  • Table 27 Global DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 28 Global NGS-Based Market, by Technology, 2022-2031 (USD Million)
  • Table 29 Global NGS Market, by Country/Region, 2022-2031 (USD Million)
  • Table 30 Global Sequencing by Synthesis Market for NGS, by Country/Region, 2022-2031 (USD Million)
  • Table 31 Global Ion Semiconductor Sequencing Market for NGS, by Country/Region, 2022-2031 (USD Million)
  • Table 32 Global Single-Molecule Real-Time (SMRT) Sequencing Market for NGS, by Country/Region, 2022-2031 (USD Million)
  • Table 33 Global DNA Nanoball Sequencing Market for NGS, by Country/Region, 2022-2031 (USD Million)
  • Table 34 Global Other NGS Sequencing Technologies Market, by Country/Region, 2022-2031 (USD Million)
  • Table 35 Global Sanger Sequencing & Pyrosequencing Market for DNA Sequencing, by Country/Region, 2022-2031 (USD Million)
  • Table 36 Global DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 37 Global DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 38 Global DNA Sequencing Market for Research & Other Applications, By Country/Region, 2022-2031 (USD Million)
  • Table 39 Global DNA Sequencing Market for Drug Discovery, by Country/Region, 2022-2031 (USD Million)
  • Table 40 Global DNA Sequencing Market for Agriculture & Animal Research, by Country/Region, 2022-2031 (USD Million)
  • Table 41 Global DNA Sequencing Market for Other Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 42 GLOBAL DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 43 GLOBAL DNA Sequencing Market for Clinical Applications, by COUNTRY/Region, 2022-2031 (USD Million)
  • Table 44 Global DNA Sequencing Market for Oncology, by Country/Region, 2022-2031 (USD Million)
  • Table 45 Global DNA Sequencing Market for Reproductive Health, by Country/Region, 2022-2031 (USD Million)
  • Table 46 HIV Prevalence among Adults, by REGION (2020 VS. 2022) (In Million)
  • Table 47 Global DNA Sequencing Market for Infectious Diseases, by Country/Region, 2022-2031 (USD Million)
  • Table 48 Global DNA Sequencing Market for Other Clinical Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 49 Global DNA Sequencing Market, By End User, 2022-2031 (USD Million)
  • Table 50 Pharmaceutical Spending in Major Countries
  • Table 51 GLOBAL DNA Sequencing Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022-2031 (USD Million)
  • Table 52 GLOBAL DNA Sequencing Market for Hospitals & Diagnostic Laboratories, by Country/Region, 2022-2031 (USD Million)
  • Table 53 Global DNA Sequencing Market for Academic & Research Institutes, by Country/Region, 2022-2031 (USD Million)
  • Table 54 Global DNA Sequencing Market for Other End Users, by Country/Region, 2022-2031 (USD Million)
  • Table 55 Global DNA Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 56 North America: DNA Sequencing Market, by Country, 2022-2031 (USD Million)
  • Table 57 North America: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 58 North America: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 59 North America: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 60 North America: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 61 North America: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 62 North America: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 63 North America: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 64 North America: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 65 North America: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 66 U.S.: Key Macroindicators & Microindicators
  • Table 67 U.S.: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 68 U.S.: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 69 U.S.: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 70 U.S.: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 71 U.S.: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 72 U.S.: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 73 U.S.: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 74 U.S.: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 75 U.S.: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 76 Some of The Key Active Genomic Projects In Canada, Along With Their Total Investments and Genome Canada Contributions, Are As Follows:
  • Table 77 Canada: Key Macroindicators & Microindicators
  • Table 78 Canada: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 79 Canada: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 80 Canada: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 81 Canada: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 82 Canada: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 83 Canada: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 84 Canada: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 85 Canada: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 86 Canada: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 87 Europe: DNA Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 88 Europe: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 89 Europe: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 90 Europe: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 91 Europe: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 92 Europe: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 93 Europe: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 94 Europe: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 95 Europe: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 96 Europe: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 97 Germany: Key Macroindicators & Microindicators
  • Table 98 Germany: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 99 Germany: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 100 Germany: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 101 Germany: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 102 Germany: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 103 Germany: DNA Sequencing Market, by APPLICATION, 2022-2031 (USD Million)
  • Table 104 Germany: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 105 Germany: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 106 Germany: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 107 France: Key Macroindicators & Microindicators
  • Table 108 France: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 109 France: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 110 France: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 111 France: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 112 France: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 113 France: DNA Sequencing Market, by APPLICATION, 2022-2031 (USD Million)
  • Table 114 France: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 115 France: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 116 France: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 117 U.K.: Key Macroindicators & Microindicators
  • Table 118 U.K.: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 119 U.K.: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 120 U.K.: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 121 U.K.: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 122 U.K.: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 123 U.K.: DNA Sequencing Market, by APPLICATION, 2022-2031 (USD Million)
  • Table 124 U.K.: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 125 U.K.: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 126 U.K.: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 127 Italy: Key Macroindicators & Microindicators
  • Table 128 Italy: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 129 Italy: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 130 Italy: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 131 Italy: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 132 Italy: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 133 Italy: DNA Sequencing Market, by APPLICATION, 2022-2031 (USD Million)
  • Table 134 Italy: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 135 Italy: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 136 Italy: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 137 Spain: Key Macroindicators & Microindicators
  • Table 138 Spain: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 139 Spain: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 140 Spain: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 141 Spain: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 142 Spain: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 143 Spain: DNA Sequencing Market, by APPLICATION, 2022-2031 (USD Million)
  • Table 144 Spain: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 145 Spain: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 146 Spain: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 147 Number of Sequences In Each Phase and Other Related Sequencing Information:
  • Table 148 ROE: Estimated Number of New Cancer Cases, by Country, 2022 VS. 2030
  • Table 149 Rest of Europe: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 150 Rest of Europe: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 151 Rest of Europe: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 152 Rest of Europe: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 153 Rest of Europe: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 154 Rest of Europe: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 155 Rest of Europe: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 156 Rest of Europe: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 157 Rest of Europe: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 158 Asia-Pacific: DNA Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 159 Asia-Pacific: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 160 Asia-Pacific: DNA Sequencing Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 161 Asia-Pacific: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 162 Asia-Pacific: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 163 Asia-Pacific: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 164 Asia-Pacific: DNA Sequencing Market, by APPLICATION, 2022-2031 (USD Million)
  • Table 165 Asia-Pacific: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 166 Asia-Pacific: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 167 Asia-Pacific: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 168 China: Key Macroindicators & Microindicators
  • Table 169 China: DNA Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 170 China: DNA Sequencing Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 171 China: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 172 China: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 173 China: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 174 China: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 175 China: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 176 China: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 177 China: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 178 Japan: Key Macroindicators & Microindicators
  • Table 179 Japan: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 180 Japan: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 181 Japan: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 182 Japan: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 183 Japan: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 184 Japan: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 185 Japan: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 186 Japan: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 187 Japan: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 188 INDIA: Key Macroindicators & Microindicators
  • Table 189 India: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 190 India: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 191 India: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 192 India: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 193 India: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 194 India: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 195 India: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 196 India: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 197 India: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 198 Rest of Asia-Pacific: Estimated Number of New Cancer Cases, by Country, 2022 VS. 2030
  • Table 199 Rest of Asia-Pacific: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 200 Rest of Asia-Pacific: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 201 Rest of Asia-Pacific: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 202 Rest of Asia-Pacific: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 203 Rest of Asia-Pacific: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 204 Rest of Asia-Pacific: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 205 Rest of Asia-Pacific: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 206 Rest of Asia-Pacific: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 207 Rest of Asia-Pacific: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 208 Latin America: DNA Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 209 Latin America: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 210 Latin America: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 211 Latin America: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 212 Latin America: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 213 Latin America: NGS-based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 214 Latin America: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 215 Latin America: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 216 Latin America: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 217 Latin America: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 218 Brazil: Key Macroindicators & Microindicators
  • Table 219 Brazil: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 220 Brazil: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 221 Brazil: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 222 Brazil: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 223 Brazil: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 224 Brazil: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 225 Brazil: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 226 Brazil: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 227 Brazil: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 228 Mexico: Key Macroindicators & Microindicators
  • Table 229 Mexico: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 230 Mexico: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 231 Mexico: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 232 Mexico: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 233 Mexico: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 234 Mexico: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 235 Mexico: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 236 Mexico: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 237 Mexico: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 238 Rest of Latin America: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 239 Rest of Latin America: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 240 Rest of Latin America: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 241 Rest of Latin America: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 242 Rest of Latin America: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 243 Rest of Latin America: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 244 Rest of Latin America: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 245 Rest of Latin America: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 246 Rest of Latin America: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 247 Middle East & Africa: DNA Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 248 Middle East & Africa: DNA Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 249 Middle East & Africa: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 250 Middle East & Africa: DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 251 Middle East & Africa: NGS-Based DNA Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 252 Middle East & Africa: DNA Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 253 Middle East & Africa: DNA Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 254 Middle East & Africa: DNA Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 255 Middle East & Africa: DNA Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 256 Recent Developments, by Company (2021-2024)
  • Table 257 Some of the Other Companies Operating in the DNA Sequencing Market

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Secondary Sources Referenced for this Study
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 Global DNA Sequencing Market, by Offering, 2024 VS. 2031 (USD Million)
  • Figure 8 Global DNA Sequencing Market, by Technology, 2024 VS. 2031 (USD Million)
  • Figure 9 Global DNA Sequencing Market, by Application, 2024 VS. 2031 (USD Million)
  • Figure 10 Global DNA Sequencing Market, by End User, 2024 VS. 2031 (USD Million)
  • Figure 11 Global DNA Sequencing Market, by Geography, 2024 VS. 2031 (USD Million)
  • Figure 12 Impact Analysis of Market Drivers, Restraints, Opportunities, and Challenges (2024-2031)
  • Figure 13 Share Of Cancer Cases, By Region, 2022 vs. 2040 (%)
  • Figure 14 Genome Sequencing Costs, 2010-2021 (USD/GENOME)
  • Figure 15 Pharmaceutical R&D Expenditures in The U.S., Europe, and China, 2010 VS. 2020 VS. 2021 (USD Million)
  • Figure 16 Global Pharmaceutical R&D Expenditure, 2014-2028 (USD Billion)
  • Figure 17 Percentage of Approved Personalized Medicines: Cancer VS. Rare Diseases VS. Other Diseases, 2022
  • Figure 19 EU Regulatory Pathway - IVDR 2017/746
  • Figure 20 China: Medical Device Classification and Premarket Requirements FOR IVD Products
  • Figure 21 Porter's Five Forces Analysis
  • Figure 22 Global DNA Sequencing Market, by offering, 2022 VS. 2031 (USD Million)
  • Figure 23 Steps of Sample Preparation in A Typical Next-Generation DNA Sequencing Workflow
  • Figure 24 Global DNA Sequencing Market, by Technology, 2024 VS. 2031 (USD Million)
  • Figure 25 Steps of DNB Sequencing Technology Include
  • Figure 26 Global DNA Sequencing Market, by Application, 2024 VS. 2031 (USD Million)
  • Figure 27 U.S.: New Molecular Entity (NME) APPROVALS
  • Figure 28 Estimated Number of New Cancer Cases (Million)
  • Figure 29 Global DNA Sequencing Market, by End User, 2024 VS. 2031 (USD Million)
  • Figure 30 Global Pharmaceutical R&D Spending, 2014-2028 (USD BILLION)
  • Figure 31 Global DNA Sequencing Market, by Geography, 2024 VS. 2031 (USD Million)
  • Figure 32 North America: DNA Sequencing Market Snapshot
  • Figure 33 U.S.: Pharmaceutical R&D Expenditure, 2014-2022 (USD Billion)
  • Figure 34 U.S.: Medical and Health R&D Investment Shares, by Source, 2020
  • Figure 35 Research Funding Supported by The Canadian Genomics Enterprise, 2022-2023 (%)
  • Figure 36 Genome Canada Funding Across Sectors, 2022-2023 (USD Million)
  • Figure 37 Europe: Pharmaceutical Industry R&D Expenditure, 2000-2022 (USD Million)
  • Figure 38 Europe: DNA Sequencing Market Snapshot
  • Figure 39 Italy: Number of Biotechnology Firms, 2014-2022
  • Figure 40 Italy: Number of Biotechnology R&D-Dedicated Firms, 2014-2022
  • Figure 41 Rest of Europe: Pharmaceutical R&D Expenditure, 2021 (USD Million)
  • Figure 42 Asia-Pacific: DNA Sequencing Market Snapshot
  • Figure 43 Japan: Pharmaceutical Industry R&D Expenditure, 2014-2022 (USD Million)
  • Figure 44 Japan: Number of New Molecular Entities Approved, 2014-2022
  • Figure 45 Latin America: DNA Sequencing Market Snapshot
  • Figure 46 Key Growth Strategies Adopted by Leading Players, 2021-2024
  • Figure 47 DNA Sequencing Market: Competitive Benchmarking by offering
  • Figure 48 DNA Sequencing Market: Competitive Benchmarking, by Region
  • Figure 49 Competitive Dashboard: DNA Sequencing Market
  • Figure 50 Global DNA Sequencing Market Share Analysis, by Key Players, 2023 (%)
  • Figure 51 Illumina, Inc.: Financial SNAPSHOT (2023)
  • Figure 52 Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
  • Figure 53 QIAGEN N.V: Financial Snapshot (2023)
  • Figure 54 Agilent Technologies, Inc.: Financial Snapshot (2023)
  • Figure 55 MGI Tech Co., Ltd.: Financial Snapshot (2023)
  • Figure 56 F. Hoffmann-La Roche Ltd.: Financial Snapshot (2023)
  • Figure 57 Revvity, Inc.: Financial Snapshot (2023)
  • Figure 58 Pacific Biosciences of California Inc.: Financial Snapshot (2023)
  • Figure 59 Danaher Corporation: Financial Snapshot (2023)
  • Figure 60 Bio-Rad Laboratories, Inc.: Financial Snapshot (2023)
  • Figure 61 Oxford Nanopore Technologies Plc.: Financial Snapshot (2023)